Answers are grounded in this paper and cite their sources.
6PPD-quinone (6PPD-Q), an oxidation product of a widely used tire antiozonant, is an emerging environmental contaminant with marked species-dependent toxicity. Its possible relevance to human endocrine tissues and adrenocortical carcinoma (ACC) remains unknown. We integrated 1,706 predicted or curated 6PPD-Q-associated genes with uniformly processed TCGA-ACC and GTEx adrenal transcriptomes, weighted gene co-expression network analysis (WGCNA), functional enrichment, protein–protein interaction analysis, machine learning with feature selection embedded in nested resampling, TCGA survival data, two independent Gene Expression Omnibus cohorts, single-nucleus RNA sequencing from 20 ACC specimens, CellChat communication inference with an AXL-edge removal analysis, a pan-cancer specificity test across 21 tumour types, reverse-phase protein array and immunohistochemistry orthogonal checks, and experimental-structure molecular docking. Among 5,404 primary differentially expressed genes, 119 overlapped both the 6PPD-Q target universe and WGCNA core modules; both headline candidates are prediction-derived rather than curated targets. CDC25C was tied at the maximum integrated evidence score with three other genes, was strongly upregulated in ACC (log2 fold change 3.31; FDR 2.21 × 10^-25), distinguished ACC from normal adrenal cortex and from adenoma in GSE10927 (AUC 0.927, 95% CI 0.84–0.99; and 0.924, 95% CI 0.86–0.99), and remained associated with shorter overall survival after age and stage adjustment (HR 2.84, 95% CI 1.54–5.24; FDR 0.011; Firth-penalised HR 2.74, 1.55–5.24). A pan-cancer test showed that the 6PPD-Q target set was not preferentially enriched in ACC relative to 20 other TCGA tumour types and that CDC25C upregulation is a pan-cancer proliferative feature rather than an ACC-specific signal; classifier performance likewise tracked cohort separability, with random gene sets of matched size performing equivalently. AXL was downregulated in bulk ACC but localised to myeloid, B-cell and pericyte/smooth-muscle compartments in all 20 specimens, and the higher-confidence GAS6-AXL ligand pairs carried 72.4% of the AXL-linked inferred communication probability. Docking supported a geometrically plausible 6PPD-Q pose in the AXL ATP pocket under a protocol validated by native-ligand redocking (heavy-atom RMSD 0.212 A); the CDC25C pose was an unvalidated pocket-feasibility result that did not contact catalytic Cys377. CDC25C and AXL are complementary, computationally prioritised candidates linking a pan-cancer tumour-cell mitotic programme and a microenvironmental communication programme to 6PPD-Q target overlap in ACC. The findings are hypothesis-generating and do not establish an ACC-specific or causal 6PPD-Q relationship; exposure-based, biochemical and functional validation is required.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: